A focus on the latest non-invasive cardiac multi-modality imaging applications, and in particular onechocardiography in heart diseases.
I SESSION Role of imaging in patients with stroke15.00 - 15.15 Cardiac source of embolism15.15 - 15.30 How to understand patent foramen ovale clinical significance15.30 - 15.45 Patients with atrial fibrillation: does imaging add to CHADVASC?15.45 - 16.00 The role of multimodality imaging16.00 - 16.15 Discussion16.15 - 16.45 Hypertrophic Cardiomyopathy: A decade of progressII SESSION Asymptomatic valvular disease: which imaging arguments to operate……or not ?17.00 - 17.15 Severe mitral regurgitation17.15 - 17.30 Severe aortic stenosis17.30 - 17.45 Severe aortic insufficiency17.45 - 18.00 Severe tricuspid regurgitation18.00 - 18.15 DiscussionIII SESSION Interactive clinical cases. Part 118.15 - 19.00IV SESSION19.00 - 19.30 Practical sessionV SESSION Incremental role of imaging in patients with arterial hypertension09.00 - 09.15 Cardiac remodeling and LV function in patients with hypertension: which news?09.15 - 09.30 Is there a place for imaging in primary and secondary prevention?09.30 - 09.50 Treatment of arterial hyper tension: state of the art09.50 - 10.10 Discussion10.10 - 10.30 Lecture: hypertension and obesity “a common but bad marriage”VI SESSION Imaging patient with dyspnoea10.30 - 10.45 Pericardial disease10.45 - 11.00 Pulmonary embolism11.00 - 11.15 Acute valvular disease11.15 - 11.30 Prosthetic valve dysfunction11.30 - 11.45 DiscussionVII SESSION11.45 - 12.30 Clinical cases. Part 2VIII SESSION12.30 - 13.00 Practical session
15.00 - 15.30 Lecture: “Heart Failure” from imaging to treatment efficacy.I SESSION Heart failure with preserved ejection fraction: state of the art15.30 - 15.45 Which news from the ESC guidelines 2016?15.45 - 16.00 Is systolic left ventricular function really normal?16.00 - 16.15 Role of exercise stress-echo16.15 - 16.30 Focal or interstitial CMR fibrosis: does it matter?16.30 - 16.45 Discussion16.45 - 17.15 BreakII SESSION Management of endocarditis in the era of multimodality imaging17.15 - 17.30 Role of echocardiography17.30 - 17.45 Role of CT and CMR17.45 - 18.00 Role of nuclear medicine18.00 - 18.20 Complications of Endocarditis: what the mind does not know, eyes do not see18.20 - 18.40 Discussion18.40 -19.10 Lecture: Bicuspid Valve state of the art.
III SESSION State of the art in “Imaging in ischemic heart disease”09.00 - 09.15 Echocardiography: is it required in all patients?... Which stress for which patients?...Echocontrastography?09.15 - 09.30 Computed tomography(CT): from anatomical to functional imaging09.30 - 09.45 Cardiovascular Magnetic Resonance (CMR): ventricular function, myocardialfibrosis, perfusion and more...09.45 - 10.00 Nuclear medicine: role of fusion imaging10.00 - 10.20 Which news in the treatment of ischemic heart disease10.20 - 10.45 DiscussionIV SESSION Myocardial strain and vortex imaging10.45 - 11.00 Use of deformation in clinical practice: tips and tricks11.00 - 11.15 Use of deformation in cardiac resynchronization therapy11.15 - 11.30 Use of deformation for inducible ischemia assessment11.30 - 11.45 Use of vortex imaging in clinical practise: tips and tricks11.45 - 12.15 Discussion12.15 - 13.15 BRUNCHV SESSION Role of imaging in oncology13.15 - 13.30 Cardiac dysfunction in patients after cancer treatment: cardiac and oncologicalimplications13.30 - 13.45 Role of imaging for the detection of subclinical dysfunction13.45 - 14.00 Vascular disease as a consequence of cancer therapy: state of the heart14.00 - 14.15 Discussion14.15 - 14.45 Prevention of embolic stroke in atrial fibrillation. Which says the lastESC guidelines?VI SESSION Imaging in rare cardiomyopathies.14.45 - 15.00 Hypereosinophilia15.00 - 15.15 Amyloidosis15.15 - 15.30 Left ventricular non compaction15.30 - 15.45 Discussion15.45 - 16.00 Closure and CME evaluation
Hilton Giardini NaxosVia Jannuzzo, 47 - 98035 Giardini Naxos (ME), Italytel. +39 0942 51931 fax +39 0942 56128
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903 Sophia Antipolis, FR
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved